# Citizens Holding Co: financial statements, quarterly

CIZN · OTC · CIK 1075706 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cizn.md) · [Financials](/companies/cizn/financials.md) · [Filings](/companies/cizn/filings.md) · [Insiders](/companies/cizn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cizn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [1,446](/filings/0001193125-22-142974.md) | [1,322](/filings/0001193125-22-213028.md) | [1,160](/filings/0001193125-22-277198.md) | [1,087 d](/filings/0001437749-24-009993.md) | [767](/filings/0001437749-23-014421.md) | [797](/filings/0001437749-23-023714.md) | [1,073](/filings/0001437749-23-031896.md) | [2,155 d](/filings/0001437749-24-009993.md) | [3,355](/filings/0001437749-23-014421.md) | [3,744](/filings/0001437749-23-023714.md) | [5,387](/filings/0001437749-23-031896.md) | [6,920 d](/filings/0001437749-24-009993.md) |
| Income tax | $k | [413](/filings/0001193125-22-142974.md) | [362](/filings/0001193125-22-213028.md) | [307](/filings/0001193125-22-277198.md) | [349 d](/filings/0001437749-24-009993.md) | [390](/filings/0001437749-23-014421.md) | [497](/filings/0001437749-23-023714.md) | [463](/filings/0001437749-23-031896.md) | [531 d](/filings/0001437749-24-009993.md) | [154](/filings/0001437749-23-014421.md) | [(79.0)](/filings/0001437749-23-023714.md) | [248](/filings/0001437749-23-031896.md) | [(397) d](/filings/0001437749-24-009993.md) |
| Net income | $k | [1,897](/filings/0001193125-22-277198.md) | [1,907](/filings/0001193125-22-277198.md) | [1,880](/filings/0001193125-22-277198.md) | [1,810 d](/filings/0001437749-24-009993.md) | [2,036](/filings/0001437749-23-031896.md) | [2,541](/filings/0001437749-23-031896.md) | [2,580](/filings/0001437749-23-031896.md) | [2,463 d](/filings/0001437749-24-009993.md) | [1,140](/filings/0001437749-23-031896.md) | [300](/filings/0001437749-23-031896.md) | [1,207](/filings/0001437749-23-031896.md) | [(793) d](/filings/0001437749-24-009993.md) |
| Diluted EPS | $ per share | [0.34](/filings/0001193125-22-142974.md) | [0.34](/filings/0001193125-22-213028.md) | [0.34](/filings/0001193125-22-277198.md) | not reported | [0.36](/filings/0001437749-23-014421.md) | [0.45](/filings/0001437749-23-023714.md) | [0.46](/filings/0001437749-23-031896.md) | not reported | [0.20](/filings/0001437749-23-014421.md) | [0.05](/filings/0001437749-23-023714.md) | [0.22](/filings/0001437749-23-031896.md) | not reported |
| Basic EPS | $ per share | [0.34](/filings/0001193125-22-142974.md) | [0.34](/filings/0001193125-22-213028.md) | [0.34](/filings/0001193125-22-277198.md) | not reported | [0.36](/filings/0001437749-23-014421.md) | [0.45](/filings/0001437749-23-023714.md) | [0.46](/filings/0001437749-23-031896.md) | not reported | [0.20](/filings/0001437749-23-014421.md) | [0.05](/filings/0001437749-23-023714.md) | [0.22](/filings/0001437749-23-031896.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.7](/filings/0001193125-21-154601.md) | [16.1](/filings/0001193125-21-238195.md) | [93.9](/filings/0001193125-21-320811.md) | [79.2](/filings/0001437749-23-006793.md) | [72.4](/filings/0001193125-22-142974.md) | [41.3](/filings/0001193125-22-213028.md) | [35.8](/filings/0001193125-22-277198.md) | [28.6](/filings/0001437749-24-009993.md) | [16.2](/filings/0001437749-23-014421.md) | [17.9](/filings/0001437749-23-023714.md) | [144](/filings/0001437749-23-031896.md) | [94.5](/filings/0001437749-24-009993.md) |
| Total assets | $m | [1,548](/filings/0001193125-21-154601.md) | [1,338](/filings/0001193125-21-238195.md) | [1,356](/filings/0001193125-21-320811.md) | [1,361](/filings/0001437749-23-006793.md) | [1,349](/filings/0001193125-22-142974.md) | [1,299](/filings/0001193125-22-213028.md) | [1,328](/filings/0001193125-22-277198.md) | [1,324](/filings/0001437749-24-009993.md) | [1,289](/filings/0001437749-23-014421.md) | [1,289](/filings/0001437749-23-023714.md) | [1,414](/filings/0001437749-23-031896.md) | [1,405](/filings/0001437749-24-009993.md) |
| Total liabilities | $m | [1,442](/filings/0001193125-21-154601.md) | [1,229](/filings/0001193125-21-238195.md) | [1,249](/filings/0001193125-21-320811.md) | [1,255](/filings/0001437749-23-006793.md) | [1,286](/filings/0001193125-22-142974.md) | [1,273](/filings/0001193125-22-213028.md) | [1,296](/filings/0001193125-22-277198.md) | [1,285](/filings/0001437749-24-009993.md) | [1,248](/filings/0001437749-23-014421.md) | [1,249](/filings/0001437749-23-023714.md) | [1,380](/filings/0001437749-23-031896.md) | [1,362](/filings/0001437749-24-009993.md) |
| Long-term debt | $m | not reported | not reported | not reported | [18.0](/filings/0001437749-23-006793.md) | not reported | not reported | not reported | [18.0](/filings/0001437749-24-009993.md) | not reported | not reported | not reported | [18.0](/filings/0001437749-24-009993.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [113](/filings/0001437749-23-006793.md) | not reported | not reported | not reported | [128](/filings/0001437749-24-009993.md) | [1.7](/filings/0001437749-23-014421.md) | not reported | not reported | [158](/filings/0001437749-24-009993.md) |
| Shareholders' equity | $m | [106](/filings/0001193125-22-277198.md) | [110](/filings/0001193125-22-277198.md) | [107](/filings/0001193125-22-277198.md) | [106](/filings/0001437749-24-009993.md) | [63.0](/filings/0001437749-23-031896.md) | [25.9](/filings/0001437749-23-031896.md) | [32.6](/filings/0001437749-23-031896.md) | [39.0](/filings/0001437749-24-009993.md) | [41.1](/filings/0001437749-23-031896.md) | [40.1](/filings/0001437749-23-031896.md) | [34.3](/filings/0001437749-23-031896.md) | [42.8](/filings/0001437749-24-009993.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,845](/filings/0001193125-22-142974.md) | [7,542 d](/filings/0001193125-22-213028.md) | [2,523 d](/filings/0001193125-22-277198.md) | [2,581 d](/filings/0001437749-24-009993.md) | [2,978](/filings/0001437749-23-014421.md) | [3,800 d](/filings/0001437749-23-023714.md) | [4,086 d](/filings/0001437749-23-031896.md) | [2,896 d](/filings/0001437749-24-009993.md) | [1,310](/filings/0001437749-23-014421.md) | [775 d](/filings/0001437749-23-023714.md) | [2,301 d](/filings/0001437749-23-031896.md) | [1,137 d](/filings/0001437749-24-009993.md) |
| Capital expenditure | $k | [259](/filings/0001193125-22-142974.md) | [70.0 d](/filings/0001193125-22-213028.md) | [1,903 d](/filings/0001193125-22-277198.md) | [367 d](/filings/0001437749-24-009993.md) | [250](/filings/0001437749-23-014421.md) | [229 d](/filings/0001437749-23-023714.md) | [1,732 d](/filings/0001437749-23-031896.md) | [431 d](/filings/0001437749-24-009993.md) | [179](/filings/0001437749-23-014421.md) | [149 d](/filings/0001437749-23-023714.md) | [305 d](/filings/0001437749-23-031896.md) | [85.0 d](/filings/0001437749-24-009993.md) |
| Dividends paid | $k | [1,341](/filings/0001193125-22-142974.md) | [1,343 d](/filings/0001193125-22-213028.md) | [1,343 d](/filings/0001193125-22-277198.md) | [1,343 d](/filings/0001437749-24-009993.md) | [1,343](/filings/0001437749-23-014421.md) | [1,345 d](/filings/0001437749-23-023714.md) | [1,345 d](/filings/0001437749-23-031896.md) | [1,344 d](/filings/0001437749-24-009993.md) | [1,346](/filings/0001437749-23-014421.md) | [898 d](/filings/0001437749-23-023714.md) | [899 d](/filings/0001437749-23-031896.md) | [899 d](/filings/0001437749-24-009993.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,581](/filings/0001193125-21-154601.md) | [5,584](/filings/0001193125-21-238195.md) | [5,581](/filings/0001193125-21-320811.md) | [5,580](/filings/0001193125-22-142974.md) | [5,585](/filings/0001193125-22-213028.md) | [5,587](/filings/0001193125-22-277198.md) | [5,587](/filings/0001437749-23-014421.md) | [5,593](/filings/0001437749-23-023714.md) | [5,595](/filings/0001437749-23-031896.md) | [5,595](/filings/0001437749-23-014421.md) | [5,601](/filings/0001437749-23-023714.md) | [5,604](/filings/0001437749-23-031896.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,624,052 at 2024-03-29, from the cover of the [10-K filed 2024-03-29](/filings/0001437749-24-009993.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.